Category - drug pricing

autm Bayh-Dole Books Business Capitol Hill Congress Department of Defense drug pricing Frederick Reinhart Government Guest Contributor Guest Contributors innovation intellectual property International IP News IPWatchdog Articles james love Japan Knowledge Ecology International Legislation Licensing NIH NIST patent Patent Reform Patents technology Technology & Innovation

Jamie Love Responds to Criticism of Knowledge Ecology International Letter

“Reinhart and AUTM are arguing that ‘obtainable to the general public on affordable phrases’ doesn’t imply the worth needs to be affordable. We disagree...

Antitrust Bayh-Dole Act Books Business Capitol Hill China Congress drug pricing Government House of Representatives independent inventor independent inventors innovation intellectual property International IP News IPWatchdog Articles Legislation patent Patents pharmaceuticals Senate technology Technology & Innovation

IP and Innovation on Capitol Hill: Week of March 4

This week on Capitol Hill and the Washington D.C. space, the Supreme Courtroom grants the petition in Iancu v. NantKwest; the U.S. Home of Representatives will...

#breakthepatent Access AIDS and Knowledge Bayh-Dole Act bio Books Business Centers for Disease Control and Prevention drug pricing Food and Drug Administration Generics Gilead Sciences Government HIV Initiative for Medicines IP News IPWatchdog Articles march-in rights National Institutes of Health orange book Patents pharmaceuticals PhRMA PrEP Technology & Innovation Truvada

Examining the Truvada #BreakThePatent Debate: Gilead Responds

We consider that one of many biggest limitations to Truvada for PrEP entry in the present day is restricted consciousness of Truvada for PrEP’s position in HIV...